Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-2 ل  2 نتائج ل ""MESH: Rituximab""

فلترة النتائج

Publisher : springer science and business media llc
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

Subjects: Male; Adult; MESH: Adenine

  • Source: J Hematol OncolJournal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-13 (2024)Journal of Hematology and OncologyJournal of Hematology and Oncology, 2024, 17 (1), pp.86.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Subjects: Male; Neoplasm, Residual; MESH: Survival Rate

  • Source: Leukemia, Vol. 35, no. 6, p. 1597-1609 (2020)LeukemiaLeukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 35 (6), pp.1597-1609. ⟨10.1038/s41375-020-01009-z⟩

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-2 ل  2 نتائج ل ""MESH: Rituximab""